Sadiq Khan joined Tevogen’s Executive Leadership Team to lead its Global Commercial organization. He brings over 30 years of commercial leadership, operations, and alliance management experience. Most recently, Sadiq served as Executive Director of Operations & Business Planning at BioCentriq where he played a key role in the creation of the CDMO specializing in cell and gene therapy manufacturing. Over the course of his career at Sanofi-Aventis and its predecessor companies, Sadiq successfully launched and managed multiple products in individual markets, regions, and globally. His experience covers over 12 therapeutic areas from specialty brands to blockbuster franchise with annual sales exceeding $1.4 billion. In addition to several country and regional commercial leadership roles in the Asia-Pacific region, he has held U.S. and global franchise leadership positions. Sadiq holds an undergraduate degree in mathematics and physics from Karachi University, and an MBA cum laude from University of Illinois at Chicago. He has been a guest speaker on topics related to biopharmaceutical commercialization, marketing, and alliance management at the Martin Tuchman School of Management at NJIT and the School of Engineering at Columbia University.Sadiq like to offer mentoring to young professionals who want to make a career in biopharmaceutical industry and enjoys hiking with his wife on the weekends.
-
Chief Commercial OfficerTevogen Bio Apr 2022 - PresentWarren County, New Jersey, United StatesMember of Tevogen’s Executive Leadership Team and responsible for leading the commercial team globally. -
Executive Director Of Operations & Business Planning,Biocentriq Sep 2018 - Mar 2022Greater New York City AreaSadiq served as Executive Director of Operations & Business Planning at BioCentriq where he played a key role in the creation of the CDMO specializing in cell and gene therapy manufacturing. He was also a member of the leadership team that prepared BioCentriq for spin-off from NJII. -
Director Of Business Development, Biopharma InnovationNew Jersey Innovation Institute Jun 2016 - Sep 2018New JerseyWorking with several academic and industry collaborators to support biopharmaceutical companies in improving the rate at which they translate discovery into commercial production. The Innovative Medicines Manufacturing Institute (IMMI), once established, will assist bio-pharmaceutical companies, regulators, and technology suppliers in addressing the need for next-generation manufacturing solutions, especially in the fields of small molecules, large molecules and cell therapy. -
Director Industry Relations - Project Market Shift (Aerospace And Defense Industry)New Jersey Innovation Institute Nov 2014 - Jun 2016Greater New York City AreaSupported manufacturers and innovative service providers within the Aerospace & Defense supplychain become competitive and resilient to the shrinking defense budgets. This was achieved through programs and services that promote diversification of portfolio, innovation in product development and collaboration.
-
Founder - Chief StrategistPharmique Health Llc Jan 2008 - Mar 2018Parsippany, New Jersey, United StatesAdvised several corporations on their strategic commercial planning, in-licensing opportunity analysis, alliance structure development, field force planning, voice of customer capturing, major market launch planning, and global/regional marketing commercial strategy optimization.Clients included start-ups to Fortune 100 companies.
-
Independent Contractor For Life Sciences AdvisoryErnst & Young May 2012 - May 2015Iselin, New JerseyIndependent consultant at Ernst and Young's global lifescience advisory practice. -
Co-FounderTegelix Therapeutics Nov 2009 - Dec 2012Parsippany, New JerseyCo-founded and lead a pharmaceutical start-up with innovative products in dermatology, specifically for treatment of pruritus, contact dermatitis, eczema and psoriasis. Project discontinued due to lack of funding. -
Ciclesonide (Asthma & Copd) Franchise Leader - Sr. Director Us MarketingSanofi-Aventis May 2005 - Dec 2007Bridgewater, NjPrepared Alvesco for US market launch in asthma indication. Also served as commercial leader for the combination product development to be indicated in asthma / COPD indications. The project was divested due to the acquisition of Altana by Nycomed and Sanofi-Aventis merger. -
Actonel (Osteoporosis) Franchise Leader - Sr. Director Global MarketingAventis 2002 - 2005Bridgewater, NjGlobal marketing leader for the Osteoporosis/Actonel team. Team leadership in repositioning Actonel franchise in all major markets and global roll-out of the once a week formulation. This resulted in conversion of a $300 million product to a $1.4 billion franchise.
-
Director New Products - Commercial Head- Global Metabolic Ta, Early Stage ProjectsGlobal Marketing - Aventis Pharmaceuticals 2000 - 2002Bridgewater, NjGlobal commercial leader for all pre-clinical to phase IIb projects in the area of diabetes, dyslipidemia and obesity.Alliance GM for Asta Medica collaboration in diabetic neuropathyCommercial lead in development of disease area strategyConducted due diligence and develop business cases for several in-licensing targets and companiesLead commercial negotiations for alliances and collaboration agreements
-
Product Group Director - Asia Pacific RegionHoechst Marion Roussel Feb 1997 - Nov 1999Birdgewater, NjAPR representative on global commercialization teams. Identify and develop marketing campaigns that create synergies between the regional countries.Responsible for cardiovascular, metabolics and CNS franchise marketing across all countries in Asia Pacific region (including Japan, China, Australia, India, Korea, Pakistan and all countries East of Pakistan.Key achievements include market development and shaping in several countries for Amaryl and Lantus through Project DAWN (Diabetes AWareness Now), a physician education project in collaboration in IDC-Minneapolis. At its peak, over 24,000 doctors were exposed to DAWN training program in ten countries. Consultant to country leadership /marketing management for product launch planning and marketing mix optimization.
-
Marketing Director - New Projects- Asia Pacific RegionHoechst Marion Roussel Nov 1998 - Dec 1999Bridgewater, NjResponsible for all pre-launch projects across seven therapeutic areas. Responsible for providing commercial insight from Asia Pacific Region (APR) and the representing regional interest in the global project teams.
Sadiq Khan Education Details
-
Business Admn -
International Business
Frequently Asked Questions about Sadiq Khan
What company does Sadiq Khan work for?
Sadiq Khan works for Tevogen Bio
What is Sadiq Khan's role at the current company?
Sadiq Khan's current role is Chief Commercial Officer @ Tevogen Bio.
What schools did Sadiq Khan attend?
Sadiq Khan attended University Of Illinois Chicago, University Of Illinois Chicago.
Not the Sadiq Khan you were looking for?
-
Sadiq Khan
New York, Ny1njit.edu1 +173234XXXXX
-
-
4optonline.net, gmail.com, hotmail.com, sanofi.com -
Sadiq Khan
New York City Metropolitan Area5gmail.com, deloitte.com, yahoo.com, bluevoyant.com, bah.com3 +120168XXXXX
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial